The Gait & Clinical Movement Analysis Society 2018 Annual Meeting
Visit us at the Gait & Clinical Movement Analysis Society 2018 Annual Meeting!
May 22-25, 2018
Stop by APDM’s booth for live demonstrations of Mobility Lab and Moveo Explorer at the Gait & Clinical Movement Analysis Society (GCMAS) Annual Meeting in Indianapolis, Indiana. Used by thousands of researchers and clinicians worldwide, Mobility Lab provides sensitive, reliable, and valid outcome measures for assessing functional mobility anywhere. These outcome measures provide actionable data for assessing populations such as Parkinson’s disease, ataxia, multiple sclerosis, cerebral palsy, Huntington’s disease, and more. Mobility Lab is now being used in clinical trials for neurological disorders like Parkinson’s disease, and genetic disorders like ataxia.
The mission of GCMAS is to improve functional outcomes and the quality of life for individuals with any movement disorder at any age. They apply the latest technology and professional knowledge to measure, evaluate, and understand human movement, provide a forum for professional interaction and exchange of ideas, promote education, stimulate research, and disseminate current knowledge and best practices to enhance human movement and health.
Whether you’re researching pathological gaits or conducting pharmaceutical clinical trials, Mobility Lab makes it easy to collect, analyze, and store data. Within minutes you can set up, attach APDM’s Opal wearable sensors to your subject, instruct them to perform a standardized test, and get instant results compared to normative values. This automated report provides spatiotemporal parameters that can track a patient’s mobility longitudinally and assist in determining intervention response over time.
APDM’s Stephanie Hertzog will be providing demonstrations of the gait and balance solution, Mobility Lab, and of the full-body kinematic analysis system, Moveo Explorer.